HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

SJ-8026

a synthetic anti-cancer agent which exhibits topoisomerase II-inhibiting activities; structure in first source

Also Known As:

N-(3-(acridin-9-ylamino)-5-hydroxymethylphenyl)-2-aminopropionamide

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 3-Ring Heterocyclic Compounds
    - Acridines: 325
      - SJ-8026: 1

Experts

1.	Cho, Eui-Hwan: 1 article (06/2005)
2.	Chung, Sun-Gan: 1 article (06/2005)
3.	Jeong, Eun-Joo: 1 article (06/2005)
4.	Joo, Jeong-Ho: 1 article (06/2005)
5.	Kang, Dong-Wook: 1 article (06/2005)
6.	Kim, Yung-Jin: 1 article (06/2005)
7.	Kwon, Ho-Seok: 1 article (06/2005)
8.	Lee, Sun-Hwan: 1 article (06/2005)
9.	Park, Si-Kyung: 1 article (06/2005)
10.	Yi, Eui-Yeun: 1 article (06/2005)

Related Diseases

1.

Neoplasms (Cancer)

06/01/2005 - "Taken together, these results suggest that SJ-8026 may be a candidate for strong anti-cancer agent with the ability to inhibit the angiogenesis of endothelial cells and to induce the apoptosis of tumor cells."
06/01/2005 - "Anti-angiogenic and anti-tumor apoptotic activities of a topoisomerase II inhibiting agent SJ-8026."
06/01/2005 - "A new piperazine derivative, SJ-8026, is a synthetic anti-cancer agent which exhibits topoisomerase II-inhibiting activities. "

Related Drugs and Biologics

1.	Type II DNA Topoisomerases (Topoisomerase II)
2.	Piperazine